A new study published in BMC Biology describes greenhouse trials of a genetically engineered diamondback moth that suppresses populations of pest diamondback moths and reduces their resistance to Bt.
Scientists at the Baker Institute for Animal Health at Cornell's College of Veterinary Medicine have developed a model system that can be used to test drugs for treating cat eye infections.
At Cornell, committed leaders, expert faculty, trained staff and student hires have worked tirelessly behind the scenes to create a winning strategy to reactivate campus and keep the community safe from COVID-19.
Physician Wayne Waz '84 spoke with students in professor Stephen Hilgartner's class on "Ethical Issues in Health and Medicine" to share his experience with the changing medical profession.
The assistant professor of biomedical engineering has been invited to the National Academy of Engineering's second annual Frontiers of Engineering Education symposium, Dec. 13-16. (Oct. 28, 2010)
The key to curing multiple sclerosis may well lie in the mysterious signaling of lipids, a major component of cells, says Cornell chemist Jeremy Baskin.
Cornell professors Laura Harrington and Alaka Basu briefed the Washington, D.C., press March 15 on the fight against the mosquito-spread Zika virus, which threatens pregnant women worldwide.
To advance a powerful cancer treatment strategy that uses immune cells to fight the disease, Ellen and Gary Davis '76 have made a $2 million gift to Weill Cornell Medicine to drive ongoing research in immunotherapy.
Cornell biomedical engineers have developed specialized white blood cells – dubbed "super natural killer cells" – that seek out cancer cells in lymph nodes with only one purpose: destroy them.